Our work in cardio-metabolic disorders. More about discovery and development. Are you passionate about building a meaningful career? We rise to any challenge to help make the greatest health impact. Supporting the future of our business and the well-being of patients, people and communities around the world. Private Securities Litigation Reform Act of There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful.
If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.
No Duty to Update The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.
By continuing, you will be directed to a site intended only for residents of the United States and Canada. Skip to content. Next story:. View our stories. Health awareness At risk for lung cancer? We are happy to help. Vianny Gutierrez-Cruz. Sales Manager — Contact United States. Ziyan Zhang. Customer Relations — Contact Asia.
Kisara Mizuno. Customer Success Manager — Contact Asia. Lodovica Biagi. Director of Operations — Contact Europe. Catalina Rodriguez. Yes, let me download! Roy Vagelos announced Merck's commitment to donate Mectizan - as much as needed for as long as needed - with the goal to help eliminate river blindness.
In order to reach this goal, Merck leaders recognized that many organizations with unique skills would need to work together as a team. Thus, the Mectizan Donation Program MDP was created as a groud-breaking public-private partnership that becomes influential in the development of a number of other drug donation programs. Prior to the FDA approval in , in conjunction with the U. Through this program, Merck made the drug available at no cost to selective patients before it was commercially available.
It was the product of nearly twenty years of research conducted at our Merck Frosst discovery hub in Kirkland, Canada, into a new class of asthma medicines called leukotriene blockers.
Merck and Schering-Plough completed a merger and began combined operations. The purchase made the company the second largest pharmaceutical company in United States by revenue. In , one woman died every two minutes during childbirth and pregnancy. Many of these deaths were preventable. In response, we launched Merck for Mothers, a global initiative with partners to improve the health and well-being of women before, during and after pregnancy and childbirth.
As of , the effort has reached more than nine million women globally in 48 countries. It had previously received breakthrough therapy designation from the FDA. From Guinea to the Democratic Republic of the Congo DRC , the world was dealing with the largest and most complex Ebola outbreaks since the virus was first discovered in As the outbreaks remained a global health challenge, scientists from Merck, along with numerous external collaborators from all sectors, remained at the forefront of the efforts to address this deadly disease.
Supporting society, people and communities around the world is fundamental to our long-term success. Private Securities Litigation Reform Act of There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful.
If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. No Duty to Update The information contained in this website was current as of the date presented.
The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date. By continuing, you will be directed to a site intended only for residents of the United States and Canada. Skip to content.
0コメント